developing a pack mentality, page-8

When it comes down to it we're all greedy pigs.

The future stock price of ACL will be determined by how the company decides to find ph3's. It could also determine wether ACL could one day be a blockbuster company, or wether they take the line of frustrated holders and look for shorter term direct rewards. Either way they will probabley be sucessfull- However It is my oponion that if we split up this company(Fonda + Oncology) then the SP combined in both, will never equate to what the SP would have been if they were both still together as ACL.

If we can't secure debt funding, then we need a rights issue-not a new company.....